Wealthcare Advisory Partners LLC Novo Nordisk A S Transaction History

Wealthcare Advisory Partners LLC

$3.49 Billion
Q4 2024

A detailed history of Wealthcare Advisory Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 25,425 shares of NVO stock, worth $2.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

25,425

Previous 14,586 74.31%

Holding current value

$2.15 Million

Previous $1.74 Million 25.98%

% of portfolio

0.06%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	BUY	$85.0 - $120.04 $921,315 - $1.3 Million	10,839 Added 74.31%	25,425 $2.19 Million
Q3 2024 Nov 04, 2024	SELL	$119.07 - $145.42 $135,501 - $165,487	-1,138 Reduced 7.24%	14,586 $1.74 Million
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $180,506 - $216,104	1,471 Added 10.32%	15,724 $2.24 Million
Q1 2024 Apr 15, 2024	BUY	$102.11 - $135.92 $407,418 - $542,320	3,990 Added 38.88%	14,253 $1.83 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $53,282 - $64,008	607 Added 6.29%	10,263 $1.06 Million
Q3 2023 Oct 12, 2023	BUY	$90.94 - $199.54 $663,407 - $1.46 Million	7,295 Added 308.98%	9,656 $878,000
Q2 2023 Jul 17, 2023	BUY	$155.98 - $172.65 $47,105 - $52,140	302 Added 14.67%	2,361 $382,000
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $30,835 - $37,079	-233 Reduced 10.17%	2,059 $327,000
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $235,044 - $310,176	2,292 New	2,292 $310,000
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $105,143 - $131,717	-1,554 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$67.06 - $75.82 $104,211 - $117,824	1,554 New	1,554 $105,000
Q2 2020 Jul 29, 2020	SELL	$58.54 - $67.94 $50,637 - $58,768	-865 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$47.54 - $53.43 $47 - $53	1 Added 0.12%	865 $45,000
Q2 2019 Jul 30, 2019	BUY	$46.79 - $52.47 $17,405 - $19,518	372 Added 75.61%	864 $44,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $13,334 - $15,167	-321 Reduced 39.48%	492 $23,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $46 - $51	1 Added 0.12%	813 $38,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $5,270 - $5,999	119 Added 17.17%	812 $37,000
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $26,759 - $30,249	563 Added 433.08%	693 $37,000
Q3 2017 Nov 15, 2017	BUY	$41.15 - $49.22 $5,349 - $6,398	130	130 $6,000

Others Institutions Holding NVO

# of Institutions

1,876

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $191B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Account

Wealthcare Advisory Partners LLC Novo Nordisk A S Transaction History